{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "BriaCell Therapeutics Corp.", "shortName": "BRIACELL THERAPEUTICS", "regularMarketPrice": 6.3, "regularMarketChangePercent": -0.7873971, "messageBoardId": "finmb_262266102", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.2218379, "fiftyTwoWeekLow": 3.926, "fiftyTwoWeekHigh": 8.096, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 2.374, "fiftyTwoWeekLowChangePercent": 0.6046867, "fiftyTwoWeekRange": "3.926 - 8.096", "fiftyTwoWeekHighChange": -1.7959995, "epsTrailingTwelveMonths": -0.5, "sharesOutstanding": 15518000, "bookValue": -0.083, "fiftyDayAverage": 6.4136, "fiftyDayAverageChange": -0.11359978, "fiftyDayAverageChangePercent": -0.017712327, "twoHundredDayAverage": 6.11673, "twoHundredDayAverageChange": 0.18326998, "twoHundredDayAverageChangePercent": 0.029962083, "marketCap": 97763400, "priceToBook": -75.90362, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1429509600000, "priceHint": 2, "regularMarketChange": -0.049999714, "regularMarketTime": 1683892036, "regularMarketDayHigh": 6.3, "regularMarketDayRange": "6.25 - 6.3", "regularMarketDayLow": 6.25, "regularMarketVolume": 150, "regularMarketPreviousClose": 6.35, "bid": 6.15, "ask": 6.3, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 6.25, "averageDailyVolume3Month": 2, "averageDailyVolume10Day": 0, "symbol": "8BTA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Bellevue Centre", "address2": "Suite 300 235 West 15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "fax": "604 921 1898", "website": "https://www.briacell.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams M.D.", "age": 65, "title": "CEO, Pres & Director", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 710992, "fmt": "710.99k", "longFmt": "710,992"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 459679, "fmt": "459.68k", "longFmt": "459,679"}}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A., MBA", "age": 49, "title": "CFO & Corp. Sec.", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 247091, "fmt": "247.09k", "longFmt": "247,091"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 208948, "fmt": "208.95k", "longFmt": "208,948"}}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 246616, "fmt": "246.62k", "longFmt": "246,616"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 438864, "fmt": "438.86k", "longFmt": "438,864"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 76, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}